Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study.

MLA

Hu, Yi, et al. “Emergence of Additional Drug Resistance during Treatment of Multidrug-Resistant Tuberculosis in China: A Prospective Cohort Study.” Clinical Microbiology & Infection, vol. 27, no. 12, Dec. 2021, pp. 1805–13. EBSCOhost, https://doi.org/10.1016/j.cmi.2021.04.001.

APA

Hu, Y., Zheng, X., Davies Forsman, L., Ning, Z., Chen, C., Gao, Y., Zhang, Z., Lu, W., Werngren, J., Bruchfeld, J., Hoffner, S., & Xu, B. (2021). Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study. Clinical Microbiology & Infection, 27(12), 1805–1813. https://doi.org/10.1016/j.cmi.2021.04.001

Chicago

Hu, Yi, Xubin Zheng, Lina Davies Forsman, Zhu Ning, Cheng Chen, Yazhou Gao, Zhengdong Zhang, et al. 2021. “Emergence of Additional Drug Resistance during Treatment of Multidrug-Resistant Tuberculosis in China: A Prospective Cohort Study.” Clinical Microbiology & Infection 27 (12): 1805–13. doi:10.1016/j.cmi.2021.04.001.